JUL 07, 2020 6:33 AM PDT

A Step Towards a Cure for Rare Polio-Like Disease in Children

WRITTEN BY: Tara Fernandez


Acute flaccid myelitis, or AFM, is a rare but devastatingly debilitating neurologic disease in children caused by a respiratory viral infection. The condition affects the nervous system, in particular the gray matter of the spinal cord which can result in sudden arm or leg weakness, a loss of reflexes, and a degeneration of muscle tone. Children affected may also experience difficulty with swallowing, neck or back pain, and drooping eyelids.

The disease, which bears symptomatic similarities to polio, has been confirmed in over 600 children in the United States since case tracking was initiated in 2014. Over 90 percent of AFM cases were reported in young children and cases appear to be on the rise. Cases often tend to peak between August and October, when respiratory viral infections often peak.

A collaborative effort between researchers at Vanderbilt, Purdue, and the University of Wisconsin-Madison have recently made a significant breakthrough in the hunt for ways to treat AFM, as described in a publication in Science Immunology. The team looked to natural immune responses for answers, identifying human monoclonal antibodies that bind specifically to the respiratory virus responsible for AFM. First identified in California in 1962, enterovirus D68 (EV-D68) belongs to a family of 100 other non-polio enteroviruses.

Antibodies are Y-shaped proteins produced by immune cells called plasma cells and play a critical role in the neutralization of invading pathogens such as bacteria and viruses. Scientists at Vanderbilt began with taking samples of these antibody-producing immune cells from children who had been infected by EV-D68. Specialized techniques were used to grow the cells under laboratory conditions and isolate the antibodies capable of most strongly binding EV-D68 and inactivating it. These, like other clinically-approved antibody-based drugs on the market, have the potential to be used therapeutically.

Next, the structure of the antibodies was analyzed by teammates at Purdue, which allowed scientists to identify the precise sites on the virus recognized by these antibodies.  Of the panel of anti-enterovirus antibodies discovered, one molecule was shown to be particularly potent at resisting infection. In a series of experiments in mice, this antibody protected the mice from symptoms including paralysis when administered prior to or subsequent to EV-D68 infection.

Further validation and clinical translation are planned as future steps for the research targeting AFM, for which there is currently no treatment or cure.

"We were excited to isolate potent human antibodies that inhibit this devastating polio-like virus, and these studies will form the basis for taking them forward to clinical trials," said Dr. James Crowe, director of the Vanderbilt Vaccine Center.

 

 

Sources: Edex Live, EurekAlert, Science Immunology.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 13, 2020
Genetics & Genomics
New Therapeutic Targets For Lupus Are Identified
JUL 13, 2020
New Therapeutic Targets For Lupus Are Identified
Advances in computational and genetic technologies have enabled scientists to search the genome to look for places where ...
JUL 23, 2020
Immunology
Cancer Therapy Reduces Lung Scarring
JUL 23, 2020
Cancer Therapy Reduces Lung Scarring
Scientists at the Stanford Institute for Stem Cell Biology and Regenerative Medicine have discovered a striking parallel ...
JUL 29, 2020
Drug Discovery & Development
Will We Have a COVID-19 Vaccine by Year-End?
JUL 29, 2020
Will We Have a COVID-19 Vaccine by Year-End?
This week, pharmaceutical companies Moderna and Pfizer launched giant Phase III 30,000-subject trials for their COVID-19 ...
AUG 12, 2020
Immunology
Is Gluten Becoming More Immunoreactive?
AUG 12, 2020
Is Gluten Becoming More Immunoreactive?
In recent years, the number of people diagnosed with celiac disease has increased drastically, even with many undiagnose ...
AUG 18, 2020
Immunology
How Dolphins Could Help Us Live Longer
AUG 18, 2020
How Dolphins Could Help Us Live Longer
Dolphins are helping scientists answer the age-old question: can we stop the clock when it comes to aging? A recent stud ...
OCT 17, 2020
Cell & Molecular Biology
Fat Droplets in Cells Help the Immune System Fight Infection
OCT 17, 2020
Fat Droplets in Cells Help the Immune System Fight Infection
Scientists have found that our immune system has a surprising helper: droplets of fat that sit inside cells.
Loading Comments...